| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-05 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.23 | 3e-05 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-05 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-05 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.29 | 4e-05 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-05 |